Trial intelligence / Profile preview

Ascorbic Acid Add-On Therapy vs Haloperidol Alone in Schizophrenia

IRCT138809201457N7Phase 4Completed

Sponsor
Mazandaran University of Medical Sciences
Start
Apr 2003
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of ascorbic acid in schizophrenia, sponsored by Mazandaran University of Medical Sciences. Started Apr 2003; status: completed.

02

Drugs

ascorbic acid
03

Conditions

schizophrenia

Beyond the preview

Go deeper on IRCT138809201457N7.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT138809201457N7.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call